Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy
Background: Omalizumab has demonstrated clinical benefits in children with moderate to severe allergic asthma. However, no studies have been performed in Japanese asthmatic children. The aim of this study was to evaluate the efficacy including free IgE suppression and safety of omalizumab in Japanes...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2015-10-01
|
| Ráidu: | Allergology International |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S132389301500115X |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|